Rockwell Medical, Inc.
RMTI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $63,359 | $44,080 | $9,966 | $38,453 |
| - Cash | $15,662 | $8,983 | $10,102 | $13,280 |
| + Debt | $13,535 | $13,439 | $16,363 | $28,895 |
| Enterprise Value | $61,232 | $48,536 | $16,227 | $54,068 |
| Revenue | $101,489 | $83,612 | $72,810 | $61,931 |
| % Growth | 21.4% | 14.8% | 17.6% | – |
| Gross Profit | $17,484 | $8,704 | $4,077 | -$2,420 |
| % Margin | 17.2% | 10.4% | 5.6% | -3.9% |
| EBITDA | $2,954 | -$4,694 | -$16,167 | -$27,799 |
| % Margin | 2.9% | -5.6% | -22.2% | -44.9% |
| Net Income | -$480 | -$8,439 | -$18,679 | -$32,674 |
| % Margin | -0.5% | -10.1% | -25.7% | -52.8% |
| EPS Diluted | -0.025 | -0.36 | -1.89 | -3.83 |
| % Growth | 93% | 81% | 50.7% | – |
| Operating Cash Flow | $4,202 | -$9,412 | -$16,929 | -$33,534 |
| Capital Expenditures | -$1,011 | -$284 | -$281 | -$522 |
| Free Cash Flow | $3,191 | -$9,696 | -$17,210 | -$34,056 |